iShares U.S. Pharmaceuticals ETF (IHE)
Description
The investment seeks to track the performance of the DJ US Select / Pharmaceutical. The IHE ETF contains 47 constituents. It is focused on growth holdings in the North America region.
Price $170.28 as of 2022-10-20Cost/Risk/Yield
| Dividend yield | 1.87% |
| Expense ratio | 0.42% |
| Average spread | 0.07% |
| 1Y roundtrip cost | 0.49% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -4.6% | -3.6% | 6.2% | -3.3% | 3.5% | -1.1% | -0.6% | -7.6% | -3.2% | 0.4% | -13.8% | ||
| 2021 | 0.2% | -0.4% | -0.4% | 0.8% | 2.9% | 1.1% | 3.2% | 0.9% | -4.9% | 2.7% | -0.5% | 7.1% | 12.8% |
| 2020 | -0.6% | -9.1% | -6.5% | 13.2% | 3.3% | -2.0% | 2.4% | 6.3% | -2.0% | -2.8% | 7.5% | 5.3% | 15.0% |
| 2019 | 4.7% | 5.0% | -0.1% | -3.0% | -5.5% | 7.3% | -4.2% | -3.6% | 0.9% | 4.4% | 3.7% | 6.2% | 15.6% |
| 2018 | 1.9% | -4.7% | -1.3% | -2.2% | 3.2% | 2.0% | 6.7% | 5.0% | -0.8% | -9.2% | 3.4% | -10.5% | -6.4% |
| 2017 | 0.2% | 8.1% | -1.3% | 1.5% | -1.7% | 3.5% | 0.1% | -0.2% | 1.1% | -3.7% | 2.2% | 0.5% | 10.6% |
| 2016 | -12.3% | -4.0% | 0.8% | 3.1% | 3.9% | -1.3% | 7.8% | -4.3% | 0.5% | -8.7% | 2.4% | 1.5% | -10.6% |
| 2015 | 2.1% | 8.9% | 2.5% | -2.6% | 5.5% | -1.1% | 3.9% | -8.1% | -11.1% | 5.2% | 4.1% | 1.0% | 10.4% |
| 2014 | 2.3% | 9.3% | -3.8% | 2.0% | 1.5% | 3.5% | -3.6% | 5.7% | 2.3% | 4.0% | 4.5% | -0.5% | 27.2% |
| 2013 | 7.3% | 1.3% | 4.2% | 3.3% | 1.7% | -0.8% | 7.4% | -2.9% | 2.6% | 2.1% | 8.0% | 1.0% | 35.2% |
| 2012 | 1.9% | 3.6% | 3.3% | 1.1% | -3.3% | 7.1% | 0.8% | -0.4% | 3.8% | -3.3% | 0.1% | -1.6% | 13.1% |
| 2011 | -1.3% | 1.9% | 3.4% | 8.5% | 2.2% | 0.1% | -2.6% | -3.1% | -3.9% | 6.0% | 5.0% | 3.8% | 20.0% |
| 1.9% | 16.3% | 7.0% | 22.4% | 17.2% | 18.3% | 21.4% | -12.3% | -14.6% | -2.7% | 40.3% | 13.8% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 0.79 | 0.72 | 0.89 | 2.40 | |||||||||
| 2021 | 0.64 | 0.72 | 0.83 | 0.79 | 2.98 | ||||||||
| 2020 | 0.59 | 0.31 | 0.71 | 0.53 | 2.14 | ||||||||
| 2019 | 0.56 | 0.54 | 0.63 | 0.52 | 2.24 | ||||||||
| 2018 | 0.53 | 0.49 | 0.40 | 0.35 | 1.77 | ||||||||
| 2017 | 0.36 | 0.92 | 0.45 | 0.37 | 2.10 | ||||||||
| 2016 | 0.31 | 0.33 | 0.32 | 0.34 | 1.30 | ||||||||
| 2015 | 0.26 | 0.39 | 0.38 | 2.09 | 3.11 | ||||||||
| 2014 | 0.28 | 0.76 | 0.39 | 0.39 | 1.82 | ||||||||
| 2013 | 0.30 | 0.33 | 0.29 | 0.28 | 1.19 | ||||||||
| 2012 | 0.30 | 0.31 | 0.66 | 0.40 | 1.67 | ||||||||
| 2011 | 0.21 | 0.23 | 0.25 | 0.22 | 0.90 | ||||||||
| 0.00 | 0.00 | 5.11 | 0.00 | 0.00 | 6.04 | 0.00 | 0.00 | 6.20 | 0.00 | 0.00 | 6.26 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| Johnson & Johnson | 22.06% |
| Pfizer Inc. | 18.80% |
| Merck & Co., Inc. | 5.35% |
| Zoetis, Inc. Class A | 4.73% |
| Eli Lilly and Company | 4.63% |
| Royalty Pharma Plc Class A | 4.60% |
| Elanco Animal Health, Inc. | 4.52% |
| Catalent Inc | 4.43% |
| Viatris, Inc. | 4.27% |
| Bristol-Myers Squibb Company | 4.10% |
| Organon & Co. | 3.29% |
| Jazz Pharmaceuticals Public Limited Company | 2.91% |
| Perrigo Co. Plc | 2.12% |
| Arvinas, Inc. | 1.33% |
| Intra-Cellular Therapies, Inc. | 1.16% |
| Top 15 Weights | 88.30% |
Compare with similar ETFs
| IHE | FXG | IBB | PBJ | PJP | UDEC | |
|---|---|---|---|---|---|---|
| Product name | iShares U.S. Pharmaceuticals ETF | First Trust Consumer Staples AlphaDEX Fund | iShares Nasdaq Biotechnology ETF | PowerShares Dynamic Food & Beverage Portfolio ETF | PowerShares Dynamic Pharmaceuticals Portfolio ETF | Innovator S&P 500 Ultra Buffer ETF December Series |
| Issuer | iShares | First Trust | iShares | Invesco | Invesco | Innovator |
| Price | $170.275 | $58.89 | $117.58 | $43.51 | $72.19 | $27.985 |
| Expense Ratio | 0.42% |  0.63% | 0.45% | 0.63% | 0.58% | 0.79% |
| Average Spread | 0.070% | 0.051% | 0.017% | 0.115% | 0.097% | 0.465% |
| AUM | $338,229,000 | $265,919,000 | $7,490,990,000 | $97,978,200 | $393,648,000 | $30,144,900 |
| Shares | 1,986,374 | 4,515,517 | 63,709,707 | 2,251,855 | 5,452,937 | 1,077,181 |
| Average Daily Volume | 10,990 | 102,669 | 1,968,141 | 73,030 | 12,790 | 9,993 |
| Home page | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site |
| Inception Date | 2006-05-01 | 2007-05-08 | 2001-02-05 | 2005-06-23 | 2005-06-23 | 2019-12-02 |
| Index Tracked | DJ US Select / Pharmaceutical | StrataQuant Consumer Staples Index | ICE Biotechnology Index | Dynamic Food & Beverage Intellidex Index | Dynamic Pharmaceutical Intellidex Index | No Underlying Index |
| Category | Health & Biotech Equities | Consumer Staples Equities | Health & Biotech Equities | Consumer Staples Equities | Health & Biotech Equities | Large Cap Blend Equities |
| Asset Class | Equity | Equity | Equity | Equity | Equity | Equity |
| Asset Class Size | Large/Mid Caps | Large/Mid Caps | Large/Mid Caps | Large/Mid/Small Caps | Large/Mid/Small Caps | |
| Value or Growth | Growth | Blend | Growth | Blend | Blend | Blend |
| Region | North America | North America | North America | North America | North America | North America |
| Countries | U.S. | U.S. | U.S. | U.S. | U.S. | U.S. |
| Annual Dividend Rate | $3.186 | $0.826 | $0.349 | $0.431 | $0.763 | $0 |
| Annual Dividend Yield | 0.019% | 0.014% | 0.003% | 0.010% | 0.011% | 0.000% |
| Number of Holdings | 47 | 42 | 267 | 29 | 22 | 0 |
| YTD Return | -13.59% | -3.93% | -22.76% | -2.68% | -10.32% | -7.60% |
| Beta | 0.83 | 0.77 | 1.25 | 0.76 | 0.84 | 0.34 |
| Upside Beta | 0.00 | -0.01 | 0.31 | 0.09 | 0.04 | 0.22 |
| Downside Beta | 0.09 | -0.01 | 0.31 | 0.10 | 0.18 | 0.02 |
| Volatility 1Y | 17.50% | 16.93% | 28.90% | 17.06% | 19.05% | 7.27% |
| Sharpe Ratio 3Y | 0.59 | 0.76 | 0.20 | 0.78 | 0.62 | 0.00 |
| Treynor Ratio 3Y | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 |